Discover how an automated monitoring method can overcome current observation protocols limitations for large-scale cell based products manufacturing. Based on the differential digital holographic microscopy, the iLine microscope has been designed to enable noninvasive, real-time observation of cells growth inside the Integrity® Xpansion™ multiplate bioreactors. The data presented highlight the benefits of differential digital holographic microscopy as a reproducible and consistent method to track cells confluence and density during large-scale production. Learn more.
By Bill Gluck, DATATRAK
More than ever, clinical studies are becoming increasingly complicated; protocols are more complex; case report forms (CRFs) are larger; clinical trials last longer and take place at sites across the globe.
By Max Blomberg, Director of Operations, Meissner Filtration Products; and Trisha Gladd, Editor, Bioresearch Online and Pharmaceutical Online
Max Blomberg, director of operations, discusses Meissner Filtration Products' recently introduced two new products related to single-use systems — a next-generation, single-use mixing system, and a plug-and-play filter solution
By Marlin Frechette, Director, Regulatory Affairs and Quality Systems, Irvine Scientific
Protecting your raw materials is a vital part of your process — and one that should be taken seriously. Repercussions such as plant shutdowns and drug shortages — stemming from events like virus contamination — can be far-reaching and difficult to overcome. To help safeguard your product, and to avoid potential adverse events, you can keep the following things in mind when sourcing media.
By Gregory Krueger, Kevin Epting, Priyanka Gupta, and Roger Alsop, Sartorius Stedim Biotech
Sartobind® Pico and Sartobind® Nano are laboratory-scale membranes, and, due to their small size and high throughput, they are perfect for use on automated chromatography systems.
By Dave Bode, VP, Health Care Solutions, DSC Logistics
Innovation defines a wide range of initiatives that supply chain leaders in life sciences companies are pursuing to best help their organizations meet the fundamental changes occurring in the industry, such as heightened regulatory enforcement, outcomes-based reimbursement, consumer vs. provider centric care, increased access to care, and new taxes. The magnitude of these changes was made perfectly clear at a healthcare conference hosted by Gartner in November 2012. The keynote speaker, Don Cassey, CEO, Medical Segment, Cardinal Health, declared that the healthcare industry must reduce its costs by 30 percent in order to remain sustainable. To put this in perspective, this means that the U.S. healthcare system would need to shed $5 Trillion in operating costs. The need and value of step change innovation in the healthcare industry will never be higher.
By Mark Mohr, CSafe Global
Ensuring that your shipment stays at the required constant temperature throughout the delivery chain requires the right packaging and handling, as the cost of losing an entire shipment of product to spoilage, and the associated damage to your business, could be disastrous.